VREX
Varex Imaging Corporation · Healthcare · Medical - Devices
Momentum inputs (comparable managers):
holder breadth -8.3% ·
share flow -1.7% ·
net new positions -9.1%
— formula
Broad distribution — falling shares and fewer holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q1 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 73 | +1 | 23.53M | $245.80M | +4 | −3 |
| Q1 2026 | 74 | -2 | 23.68M | $251.27M | +5 | −7 |
| Q4 2025 | 76 | +1 | 25.15M | $293.07M | +1 | — |
| Q3 2025 | 16 | 0 | 13.89M | $172.28M | +1 | −1 |
| Q2 2025 | 13 | -1 | 12.33M | $106.93M | +1 | −2 |
| Q1 2025 | 11 | -1 | 6.63M | $76.87M | — | −1 |
| Q4 2024 | 12 | 0 | 6.74M | $98.34M | +1 | −1 |
| Q3 2024 | 11 | +1 | 5.38M | $64.17M | +3 | −2 |
| Q2 2024 | 10 | — | 2.74M | $40.40M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (passive) | 1.76M | -0.1% | $20.40M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 2 | Wellington Management ✦ | 1.55M | +5.9% | $17.93M | 0.0% | ▲ Add | 3 | SEC ↗ ×4 |
| 3 | Geode Capital Management ✦ (passive) | 962.77K | +3.5% | $11.17M | 0.0% | ▲ Add | 4 | SEC ↗ ×2 |
| 4 | Millennium Management ✦ | 455.96K | -33.7% | $5.29M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 5 | D. E. Shaw & Co. ✦ | 427.59K | +12.1% | $4.96M | 0.0% | ▲ Add | 4 | SEC ↗ ×2 |
| 6 | Citadel Advisors ✦ | 365.58K | +61.3% | $4.24M | 0.0% | ▲ Add | 4 | SEC ↗ ×2 |
| 7 | AQR Capital Management ✦ | 313.75K | -45.0% | $3.64M | 0.0% | ▼ Trim | 4 | SEC ↗ ×5 |
| 8 | Renaissance Technologies ✦ | 308.70K | +18.9% | $3.58M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 9 | Marshall Wace ✦ | 247.58K | +1512.2% | $2.87M | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 10 | Two Sigma Investments ✦ | 222.83K | +55.4% | $2.58M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 11 | T. Rowe Price ✦ | 16.94K | +9.9% | $197,000 | 0.0% | ▲ Add | 4 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| Arrowstreet Capital | $4.21M | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 176 holders, 41.13M shares, $401.23M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Director · 8.12K sh · $150,076
Officer · 130.00K sh · $2.40M
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology